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Abstract: Annona squamosa is generally referred to as a ‘custard apple’. Antidiabetic actions of hot
water extract of Annona squamosa (HWAS) leaves together with isolation of active insulinotropic
compounds were studied. Insulin release, membrane potential and intracellular Ca2+ were determined
using BRIN-BD11 cells and isolated mouse islets. 3T3L1 adipocytes and in vitro models were used to
determine cellular glucose uptake, insulin action, starch digestion, glucose diffusion, DPP-IV activity
and glycation. Glucose intolerant high-fat fed rats were used for in vivo studies. Active compounds
were isolated and characterized by HPLC, LCMS and NMR. HWAS stimulated insulin release from
clonal β-cells and mouse islets. Using fluorescent indicator dyes and modulators of insulin secretion,
effects could be attributed to depolarization of β-cells and influx of Ca2+. Secretion was stimulated
by isobutylmethylxanthine (IBMX), tolbutamide or 30 mM KCl, indicating additional non-KATP
dependent pathways. Extract stimulated cellular glucose uptake and insulin action and inhibited
starch digestion, protein glycation, DPP-IV enzyme activity and glucose diffusion. Oral HWAS
improved glucose tolerance and plasma insulin in high-fat fed obese rats. Treatment for 9 days
with HWAS (250 mg/5 mL/kg), partially normalised energy intake, body weight, pancreatic insulin
content, and both islet size and beta cell mass. This was associated with improved oral glucose
tolerance, increased plasma insulin and inhibition of plasma DPP-IV activity. Isolated insulinotropic
compounds, including rutin (C27H30O16), recapitulated the positive actions of HWAS on beta cells
and in vivo glucose tolerance and plasma insulin responses. Annona squamosa is attractive as a dietary
adjunct in treatment of T2DM and as a source of potential antidiabetic agents including rutin.
Keywords: diabetes; phytochemicals; glucose; insulin; DPP-IV
1. Introduction
Around 2.8% of the world’s population has diabetes mellitus and it is anticipated to increase to
5.4% of the disease representing 90–95% of the total number of cases [1]. In type 2 diabetes mellitus
(T2DM), pancreatic β-cell function is impaired and insulin resistance occurs in hepatic and peripheral
tissues, resulting in unrestrained hepatic glucose output and impaired peripheral glucose uptake [2].
Oral hypoglyceamic agents (OHAs) can reduce insulin resistance and facilitate insulin secretion during
the early stage of the disease [3,4]. However, more intensive therapy increases the risk of developing
gastrointestinal disturbances, weight gain, diarrhea, renal failure and hypoglycaemia [5]. In many
countries, such drugs are not freely available, so one avenue to combat T2DM is to use natural sources
such as medicinal plants and animal products [6,7].
Herbal medicines have been valuable source of pharmacological therapeutics for diabetes that
predates the discovery of insulin and other pharmacological treatments. In an attempt to develop
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more effective and adjunctive therapy, they have become a growing part of modern medicine [8].
Different plants have been studied in recent times to evaluate their antihyperglycaemic properties [6].
The active phytoconstituents with insulinotropic, insulin mimetic or glucose lowering action of these
plants have been also investigated [9]. The anti-hyperglyceamic activity is mainly due to their ability
to restore endocrine pancreatic function by increasing the insulin output, inhibiting the intestinal
glucose absorption and/or facilitating insulin action [10]. To date, more than 400 plant species have
been identified having hypoglyceamic activity, and yet new compounds are being searched for greater
efficacy [11].
Annona squamosa, locally known as ‘Ata’ belongs to the Annonaceae family and is a small tree
native to Bangladesh. The plant is well known locally for different therapeutic attributes such as
antioxidant, antidiabetic and hepatoprotective activity [12]. Several phytochemicals have been isolated
from different fractions of A. squamosa including alkaloids, terpenoids, phenolics, wax and fats,
kaempferol, farmarixetin, tannins, flavonoids and steroids [13,14]. Several animal models studies
using A. squamosa have shown reduction of total cholesterol, LDL and triglyceride, but increased
HDL [15,16]. A. squamosa also appeared to have the ability to reduce blood glucose and increase plasma
insulin levels [17] and to protect from pancreatic β-cells from damage due to oxidative stress [18–21].
In addition, the plant has been reported to have hepatoprotective properties. Similarly, another study
reported A. squamosa extract reduced liver toxicity induced by isoniazid plus rifampicin [22]. Other
notable pharmacological properties reported include anti-depressant, analgesic, anti-inflammatory [23]
and anti-bacterial effects [23].
Despite these studies, the full mechanism of action of A. squamosa is unknown and, the present
study investigated a broad spectrum of actions of A. squamosa as a possible anti-diabetic agent.
This included evaluation of effects of hot water extract of A. squamosa leaves on insulin secretion,
cellular glucose uptake, starch digestion, glucose diffusion, DPP-IV activity and protein glycation.
Furthermore, the acute and long-term effects of A. squamosa in vivo were evaluated in normal and
high-fat-fed diabetic rats. Rats were treated with A. squamosa orally (250 mg/5 mL/kg body weight)
for 9 days. Oral glucose tolerance, plasma DPP-IV activity, islet morphology and body weight were
investigated. Finally, the active compounds from A. squamosa extract responsible for increased insulin
secretion were isolated using RP-HPLC and their mass to charge ratio and identity were defined
by NMR.
2. Materials and Methods
2.1. Collection and Preparation of Plant Extracts
Annona squamosa leaves were obtained from the University Ayurvedic Research Centre (UARC),
Jahangirnagar University, Dhaka, Bangladesh. The plant material was identified and documented
by the botanical taxonomist Bangladesh National Herbarium, Mirpur, Dhaka, and given accession
number 43754. Plant leaves were washed and air-dried, before proceeding with hot water extraction.
Twenty-five grams of the dried powder of leaves were added to 1 L of water and heated. When it
reached the boiling point, the blend was allowed to stand for 15 min prior to separation using filter
paper (Whatman no. 1 filter paper). The oily-separated solution was then dried under a vacuum
(Savant Speed vac; New York, NY, USA) to leave a final sticky residue of the plant extract. This was
collected and stored at 4 ◦C until the bioassay was performed [24].
2.2. In Vitro Insulin-Releasing Studies
The insulin-releasing effects of plant extract were tested using BRIN-BD11 cells and isolated mouse
islets as described previously [11]. A range of concentrations of plant extract or known modulators of
insulin secretion were incubated with BRIN-BD11 cells in the presence or absence of glucose (1.1, 5.6 or
16.7 mM) during 20 min incubation at 37 ◦C. Islets were isolated from the pancreas of albino Swiss mice
(40–50 gm) by digesting with collagenase P from Clostridium histolyticum (Sigma-Aldrich, Dorset, UK).
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Islets were cultured for 48 h, and then subjected to an insulin-release studies as described previously [11].
The supernatants were stored at −20 ◦C for insulin radioimmunoassay, and the islets were retrieved to
measure islet insulin content following acid-ethanol extraction [25]. To elucidate secretory pathways
triggered by A. squamosa, these studies included evaluation of effects of known modulators of insulin
secretion including diazoxide (KATP-channel opener), tolbutamide (sulphonylurea and KATP-channel
blocker), verapamil (voltage-dependent Ca2+ channel blocker), IBMX (phosphodiesterase inhibitor),
30 mM KCl and 10 mM alanine which both depolarize the plasma membrane and induce Ca2+ influx.
The amino acid alanine achieves this largely by co-transport with Na+ plus metabolism with ATP
generation [26].
2.3. Membrane Potential and Intracellular Calcium ([Ca2+]i) Concentration
Changes in membrane potential and intracellular [Ca2+]i concentrations of BRIN-BD11 cells in
response to exposure to hot water extract of A. squamosa were determined using a FLIPR Membrane
Potential Assay Kit and a FLIPR Calcium 5 Assay Kit (Molecular Devices, Sunnyvale, CA, USA) as
described previously [27]. A depolarising concentration of 30 mM KCl and 10 mM alanine were used
as positive controls.
2.4. Glucose Uptake Assay
The 3T3L1 fibroblast cell monolayers were differentiated in culture to adipocytes as reported
previously [28]. 50 µL of 200 µg/mL reconstituted plant extract with or without 100 nM insulin was
added to each well of 3T3-L1 differentiated cells and incubated for 30 min at 37 ◦C in an atmosphere
of 5% CO2 and 95% air. 2-NBDG, 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose
(50 nM) was added. After 5 min, the wells were washed with ice-cold PBS and three to four coverslips
were mounted in each slide and blocked with nail polish. Four images were taken of the four corners of
the coverslips using a 10×magnification on the microscope. The fluorescence intensity was measured.
2.5. Glycation of Insulin
The effects of plant extract on in vitro protein glycation were determined as described previously [29].
Plant extract and glucose solutions were prepared in 10 mM sodium phosphate buffer (pH 7.4). 246.5 mM
D-glucose and NaBH3CN (0.0853 gm/mL) were incubated with or without plant extract (50, 100,
200 µg/mL) in the presence of human insulin (1 mg/mL) at 37 ◦C for 24 h in a total volume 1 mL (pH 7.4).
The reaction was stopped by addition of 30 µL of 0.5 M acetic acid. Separation and quantification of
glycated and non-glycated insulin were performed using reversed-phase high-performance liquid
chromatography [30]. Aminoguanidine, an established inhibitor of protein glycation was used as a
positive control.
2.6. DPP-IV Enzyme Activity In Vitro
Effects of A. squamosa on DPP-IV enzyme activity were determined using a fluorometric method.
Enzyme activity were determined using 96-well black-walled, clear-bottomed microplates (Greiner)
containing 8 mU/mL of DPP-IV enzyme and 200 µM of substrate (Gly-Pro-AMC) as described
previously [31]. Flex Station 3 (Molecular Devices, Sunnyvale, CA, USA) was used to measure the
changes in fluorescence with an excitation and emission at 370 and 440 nm with 2.5 nm slit width.
Established DPP-IV inhibitors, sitagliptin and vildagliptin were used as positive controls.
2.7. Starch Digestion
The starch digestion studies were performed as described previously [32]. Starch (100 mg)
(Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 3 mL of distilled water with or without plant
extract (62.5–1000 µg/mL) and acarbose (62.5–1000 µg/mL), an established α-glucosidase inhibitor, as a
positive control. 40 µl of 0.01% heat stable α-amylase (from Bacillus leicheniformis, Sigma-Aldrich,
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St. Louis, MO, USA) was added. After incubation at 80 ◦C for 20 min, the mixture was diluted to 10 mL and
1 mL was incubated with 2 mL of 0.1 M sodium acetate buffer (pH 4.75) and 30 µL of 0.1% amyloglucosidase
from Rhizopus mold (Sigma-Aldrich, St. Louis, MO, USA) for 30 min at 60 ◦C. The samples were analysed
for glucose liberation using liquid GOD/PAP (glucose oxidase/four-aminophenazone-phenol) method
(Randox GL 2623). The samples were measured at 500 nm against a blank reagent at 37 ◦C.
2.8. Glucose Diffusion In Vitro
The in vitro glucose diffusion model was based on a cellulose ester (CE) dialysis tubes
(20 cm × 7.5 mm, Spectra/Por®CE layer, MWCO: 2000, Spectrum, Amsterdam, The Netherland).
Briefly, a 2 mL volume of 0.9% NaCl (BDH Chemicals Ltd., Poole, UK) supplemented with 220 mM
glucose was placed into dialysis tube either in the presence or absence of plant extract/gaur gum
(0.2–25 mg/mL). The latter agent is well known to increase viscosity and slow intestinal glucose
absorption. Both ends of each tube were sealed tightly and placed in a 50 mL centrifuge tube (Orange
Scientific, Orange, CA, USA) containing 0.9% NaCl (45 mL). The tubes were put on an orbital shaker
and maintained at 37 ◦C during shaking for 24 h with samples taken for glucose analysis as described
previously [33].
2.9. Animals
Sprague-Dawley male rats (Envigo UK, approximately 350–400 g) were fed a high-fat diet (20%
protein, 45% fat and 35% carbohydrate; 26.15 KJ/g total energy percent (Special Diet Service, Essex,
UK) 5–6 weeks before the start of experimentations. Age-matched rats maintained on standard
rodent maintenance diet (10% fat, 30% protein and 60% carbohydrate making 12.99 KJ/g total energy,
Trouw Nutrition, Cheshire, UK) were used as controls. All studies were approved by the Animal
Welfare and Ethical Review Board (AWERB) at Ulster University and conducted in accordance to UK
Animals (Scientific Procedures) Act 1986 and EU Directive 2010/63EU. All necessary steps were taken
to prevent any potential animal suffering.
2.10. Oral Glucose Tolerance
To evaluate the effects of hot water extract of A. squamosa leaves and their isolated compound
(rutin) on glycaemic control, oral glucose tolerance tests were performed using high-fat-fed rats
(380–400 gm body wt.). Blood samples were collected at times indicated in Figures before and after oral
administration of glucose (18 mmol/kg body weight) without and with plant extract (250 mg/5 mL/kg).
Plasma was separated from the whole blood by centrifugation for 5 min at 12,000 rpm at 4 ◦C and stored
at −20 ◦C prior to analysis of insulin. An Ascencia Contour glucose meter (Bayer, Newbury, UK) was
used to measure blood glucose and insulin was determined by dextran-charcoal radioimmunoassay [11].
2.11. DPP-IV Enzyme Activity In Vivo
The effects of plant extract on activity of DPP-IV was determined in plasma by a fluorometric assay
based on the liberation of AMC (7-Amino-4-Methyl-Coumarin) from DPP-IV substrate, Gly-Pro-AMC
with the modification as described previously [34]. Blood samples were obtained from high-fat-fed rats
at times indicated in Figure after oral administration of plant extract (250 mg/5 mL/kg), the established
DPP-IV inhibitors sitagliptin (10 µmol/5 mL/kg) and vildagliptin (10 µmol/5 mL/kg) or saline control.
2.12. Glucose Homeostasis after 9-Days Treatment with Hot Water Extract of A. squamosa Leaves in High-Fat
Fed Rats
High-fat fed adult, male Sprague-Dawley rats were administered twice-daily oral gavage dose of
either saline vehicle (0.9% w/v) or plant extract (250 mg/5 mL/kg body weight) for 9 consecutive days.
Food intake, fluid consumption, body weight and circulating glucose and insulin were measured
before and at regular intervals. Glucose tolerance (18 mmol/kg body weight) was evaluated after
Plants 2020, 9, 1348 5 of 26
6 days of treatment. At the end of study, pancreata were collected for analysis of islet morphology and
pancreatic insulin content [11].
2.13. Islet Morphology after 9-Days Treatment with Hot Water Extract of A. squamosa Leaves in High-Fat
Fed Rats
Pancreata excised from high-fat fed (treated or untreated) and normal rats (control) were placed
in 4% paraformaldehyde at 4 ◦C for 48 h and an automated tissue processor was used to process the
tissues. Tissue staining and their analysis were conducted as previously described [35]. Sections (5 to
8 µM) were placed on slides and dewaxed and rehydrated. A 2% BSA buffer was used for 30 min
for blocking, and slides were incubated overnight at 4 ◦C with primary antibody (mouse anti-insulin
(1:500) and guinea pig anti-glucagon (1:400). The slides were incubated at room temperature with
secondary antibody mixture (Alexa Fluor 594 goat anti-mouse antibody and Alexa Fluor 488 goat
anti-guinea pig antibody). After staining the nucleus with 4′,6-diamidino-2-phenylindole (DAPI),
the slides were mounted using anti-fade mounting medium. Then the slides were subjected for
analysis using tetramethylrhodamine isothiocyanate (594 nm) or fluorescein isothiocyanate filters
(488 nm) using a fluorescent microscope (Olympus System Microscope BX51, Olympus Instruments,
London, UK). Images were captured using a DP70camera adapter system. CellˆF imaging software
(Olympus System Microscope BX51, Olympus instruments, London, UK) was used to determine islet
distribution, islet area, beta cell and alpha cell area.
2.14. Purification of Crude Extracts
Crude extracts were re-dissolved in solvent (0.12% (v/v) TFA/Water) and purified by reversed-phase
high-performance liquid chromatography. The extract solution was injected onto a (22 × 250 mm)
Vydac 218TP1022 10 µm (C-18) reversed-phase HPLC column (Grace, Deerfield, IL, USA) equilibrated
with 0.12% (v/v) TFA/water at a flow rate of 5 mL/min. The concentration of acetonitrile within the
eluting solvent was expanded using linear gradients to 20% over 10 min, 70% over a period of 40 min.
The wavelength of 254 nm and 360 nm were used to measure the absorbance and fractions were
collected according to the appearance of peaks in individual time points. Further, insulinotropic
fractions were purified using Vydac 208TP510 (10 × 250 mm) semi-preparative stainless steel 5 µm
C-18 column (Phenomenex, London, UK). Acetonitrile concentration in the eluting solvent was same
as above at a flow rate of 1 mL/min.
2.15. Structural Characterization of Purified Extracts
Molecular weights of fractions (peak samples) were determined using Liquid
Chromatography-Mass Spectrometry (LC-MS) via Electrospray ionization mass spectrometry (ESI-MS).
Fractions (peak samples) were separated on a Spectra System LC (Thermo Separation Products) using
a Kinetex 5 µm F5 LC column ((150 × 4.6 mm) (Phenomenex)). A 10 µL volume was chromatographed
at ambient temperature using gradient elution. The column was allowed to equilibrate for 10 min
at 80% water: 20% acetonitrile, then increasing to 70% acetonitrile over 20 min and returning to the
initial conditions for 5 min to allow re-equilibration before the next injection. A flow rate of 1 mL/min
was maintained over the 35 min run time with UV detection at 220–360 nm. The LC effluent was
routed to an LCQ electrospray ion trap mass spectrometer (Thermo Finnigan, San Jose, CA, USA) for
mass characterization. The system was controlled using Xcalibur software (Thermo Scientific, CA,
USA) and operated in negative ion mode, scanning over the mass range m/z 150.0–1200.0 Da. Nitrogen
gas for the sheath and auxiliary gas were set 65 and 8 arbitrary units respectively. The spray voltage
was set to 4.5 kV and the heated capillary temperature maintained at 250 ◦C. The precision level of the
instrument was ±0.02%.
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2.16. Confirmation of Extract Purity and Identity
All nuclear magnetic resonance (NMR) spectra were physically staged and routinely baseline
corrected as described previously by Grace et al. [36] for compound identity confirmation followed by
HPLC and LC-MS analysis. NMR spectra had been recorded on a 600 MHz Bruker AVIII HD (Bruker
BioSpin, Coventry, UK) spectrometer outfitted with a 5 mm BBO H & F cryogenic test. Standard
one-dimensional composite pulse sequencing (zgcppr) was used to obtain 1H NMR spectra. The 13C
NMR spectra were obtained with the aid of the use of the reverse gated-decoupling pulse sequence
(zgig) and the purchase parameters were set as described previously [36].
2.17. Statistical Analysis
A statistical analysis software for windows, Graph Pad prism 5, used for all types of analysis
and interpretation of data. All data were analysed by unpaired Student’s t test (nonparametric, with
two-tailed p-values) and one-way ANOVA with Bonferroni post hoc tests wherever applicable. To plot
area under the curve (AUC) with baseline correction, trapezoidal rules were followed. Values were
presented as mean ± SEM; the significant limit was determined as p < 0.05.
3. Results
3.1. Effects of A. squamosa Leaves on Insulin Release from BRIN-BD11 Cells
Insulin secretion from BRIN-BD11 cells was increased (p < 0.05–p < 0.001) in a concentration
(40–5000 µg/mL) dependent manner by hot water extract of A. squamosa at both 5.6 mM and 16.7 mM
glucose (Figure 1A,B). Insulin secretagogues, alanine (10 mM) and membrane depolarizing agent,
KCl (30 mM) were used as positive controls. Extract concentrations up to 200 µg/mL did not affect cell
viability, but higher concentrations increased release of LDH levels by 16% to 60% (data not shown).
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Figure 1. Dose-dependent effects hot water extract of A. squamosa leaves on insulin release from (A,B) 
BRIN-BD11 cells and (C) isolated pancreatic islets, (D) protein glycation, (E) insulin secretion in the 
presence or absence of established stimulators or inhibitors and (F) extracellular calcium from BRIN 
BD11 cells. Values are Mean ± SEM for n = 8 and 4 for insulin release and n = 3 for protein glycation. 
* p < 0.05, ** p < 0.01 and *** p < 0.001 compared to control (5.6/16.7 mM glucose and 220 mM glucose 
+ insulin (1 mg/mL)). ϕ p < 0.05, ϕϕ p < 0.01 and ϕϕϕ p < 0.001 compared to 5.6 mM glucose in the presence 
of the extract for (E,F). Δ p < 0.05, ΔΔ p < 0.01, ΔΔΔ p < 0.001 compared to respective incubation in the 
absence of the extracts for (E,F). ΨΨΨ p < 0.001 compared to alanine in the presence of 16.7 mM glucose 
for (C). 
3.2. Effects of A. squamosa Leaves on Insulin Release from Isolated Mouse Islets 
Hot water extract of A. squamosa induced concentration dependent (25–200 µg/mL) stimulation 
of glucose-induced insulin secretion by 1.4–2.5-fold compared to control (16.7 mM glucose alone) (p 
< 0.01–0.001, Figure 1C). Glucose dependent insulin secretion modulator, GLP-1 (10−6 and 10−8 M) and 
alanine (10 mM) used as positive controls also significantly increased insulin release (p < 0.001; Figure 
1C). 
Figure 1. Dose-dependent effects hot water extract of A. squamosa leaves on insulin release from (A,B)
BRIN-BD11 cells and (C) isolated pancreatic islets, (D) protein glycation, (E) insulin secretion in the
presence or absence of established stimulators or inhibitors and (F) extracellular calcium from BRIN
BD11 cells. Values are Mean ± SEM for n = 8 and 4 for insulin release and n = 3 for protein glycation.
* p < 0.05, ** p < 0.01 and *** p < 0.001 compared to control (5.6/16.7 mM glucose and 220 mM glucose
+ insulin (1 mg/mL)). φ p < 0.05, φφ p < 0.01 and φφφ p < 0.001 co pared to 5.6 mM glucose in the
presence of the extract for (E,F). ∆ p < 0.05, ∆∆ p < 0.01, ∆∆∆ p < 0.001 compared to respective incubation
in the absence of the extracts for (E,F). ΨΨΨ p < 0.001 compared to alanine in the presence of 16.7 mM
glucose for (C).
3.2. Effects of A. squamosa Leaves on Insulin Release from Isolated Mouse Islets
Hot water extract of A. squamosa induced concentration dependent (25–200 µg/mL) stimulation
of gluc se-induced insulin secretion by 1.4–2.5-fold compared to control (16.7 mM glucose alone)
(p < 0.01–0.001, Figure 1C). Glucose dependent insulin secretion modulator, GLP-1 (10−6 and 10−8 M)
and alanine (10 mM) used as positive controls also significa tly increased insulin release (p < 0.001;
Figure 1C).
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3.3. Effects of A. squamosa Leaves on Protein Glycation In Vitro
The effects of hot water extract of A. squamosa (HWAS) on protein glycation are illustrated in
Figure 1D. Aminoguanidine (44 mM) used as a positive control inhibited insulin glycation by 82.7%
(p < 0.001, Figure 1D). Insulin glycation was decreased by 12–50% in a concentration-dependent manner
by the 50–200 µg/mL hot water extract (p < 0.05–0.001, Figure 1D).
3.4. Effects of A. squamosa Leaves on Insulin Release in the Presence of Known Modulators of Insulin Secretion
and Absence of Extracellular Calcium from BRIN BD11 Cells
Additional studies were performed to understand the mechanism underlying the insulin secretory
actions of non-toxic concentration (200 µg/mL) of A. squamosa extract. As shown in Figure 1E,
A. squamosa induced insulin release (p < 0.001) was enhanced by various modulators including,
16.7 mM glucose (p < 0.05), isobutylmethylxanthine (IBMX; p < 0.001) and tolbutamide (p < 0.001).
Cyclic AMP production and insulin secretion were amplified using the phosphodiesterase inhibitor
IBMX and the sulphonylurea, tolbutamide. On the other hand, the presence of diazoxide, a KATP
channel opener and verapamil, voltage-gated calcium channel blocker significantly inhibited the
insulin releasing effect by decreasing the influx of intracellular Ca2+ (p < 0.001). The extract maintained
its ability to increase insulin secretion from the cells depolarized with 30 mM KCl (p < 0.001; Figure 1E)
but absence of added Ca2+ ions to the incubation buffer reduced but did not entirely abolish the
insulin-releasing activity of the plant (p < 0.001; Figure 1F).
3.5. Effects of A. squamosa Leaves on Membrane Depolarization and Intracellular Calcium from BRIN
BD11 Cells
As shown in Figure 2A,B, the hot water extract induced membrane depolarization (p < 0.001,
Figure 2A) and caused a significant increase in intracellular calcium ion concentration in BRIN-BD11
cells at 5.6 mM glucose (p < 0.001, Figure 2B). Both, KCl (30 mM) and alanine (10 mM) were used as
positive controls caused depolarization and increased intracellular calcium ions (p < 0.001, Figure 2A,B)
compared to the control (5.6 mM glucose alone).
3.6. Effects of A. squamosa Leaves on Glucose Uptake and Insulin Action
The effects of A. squamosa on glucose uptake and insulin action were determined by 2-NBDG
(2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose) fluorescent hexose, a glucose
analogue using the 3T3L1 adipocyte cells. Figure 2C–F show the microscopic fluorescence intensity
images of 2-NBDG uptake. A. squamosa (200 µg/mL) increased glucose uptake by 1.2-fold in 3T3L1
differentiated adipocyte cells compared to control (p < 0.05–0.001, Figure 2G). This effect was not
associated with toxic effects on 3T3L1 cells. In the presence of insulin (100 nM), hot water extract of
A. squamosa leaves showed the greatest cellular intensity of 2-NDBG fluorescence (p < 0.001, Figure 2G).
Hot water extract increased glucose uptake in 3T3L1 adipocyte cells by 30% in the presence of insulin
(100 nM) and by 20% in the absence of insulin (Figure 2G).
3.7. Effects of A. squamosa Leaves on Starch Digestion In Vitro
The effects of A. squamosa on starch digestion are presented in Figure 2H,I. Acarbose (62.5–1000 µg/mL)
used as positive control produced 17–72% concentration-dependent decrease in starch digestion (Figure 2H).
At the higher concentrations (500–1000 µg/mL), the hot water extract of A. squamosa significantly
(p < 0.05–0.01, Figure 2I) inhibited starch digestion by 18–28%.
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Figure 2. Effects of hot water extract of A. squamosa leaves on (A) membrane potential and (B) intracellular calcium in BRIN BD11 cells, (C–G) glucose uptake in 
differentiated 3T3L1 adipocyte cells, (H,I) starch digestion and (J) glucose diffusion in vitro. Changes of fluorescence intensity in differentiated 3T3L1 adipocytes 
incubated with hot water extract of A. squamosa leaves (HWAS; 200 µg/mL) + 50 nM 2-NBDG in the (E) absence or (F) presence of 100 nM insulin. Images were taken 
at 10× magnification. Values are Mean ± SEM for n = 6 for membrane potential and intracellular calcium, n = 4 for glucose uptake, starch digestion and glucose 
diffusion. * p < 0.05, ** p < 0.01 and *** p < 0.001 compared to control. 
Figure 2. Effects of hot water extract of A. squamosa leaves on (A) membrane potential and (B) intracellular calcium in BRIN BD11 cells, (C–G) glucose uptake in
differentiated 3T3L1 adipocyte cells, (H,I) starch digestion and (J) glucose diffusion in vitro. Changes of fluorescence intensity in differentiated 3T3L1 adipocytes
incubated with hot water extract of A. squamosa leaves (HWAS; 200 µg/mL) + 50 nM 2-NBDG in the (E) absence or (F) prese ce of 100 nM i sulin. Images were taken at
10×magnification. Valu s are Mean ± SEM for n = 6 for membrane potential and intracellular calcium, n = 4 for glucos uptake, starch digestion and lucose diffusion.
* p < 0.05, ** p < 0.01 and *** p < 0.001 compared to control.
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3.8. Effects of A. squamosa Leaves on Glucose Diffusion In Vitro
Hot water extract of A. squamosa resulted in a significant (p < 0.05–0.01) inhibition of glucose
diffusion over 24-h incubation as compared to the control. As shown in Figure 2J, the extract decreased
the total diffusion of glucose by 10–30% with maximal effect at a concentration of 25,000 µg/mL (30%,
Figure 2J).
3.9. Effects of A. squamosa Leaves on DPP-IV Enzyme Activity In Vitro
The in vitro DPP-IV enzyme inhibitory effects of sitagliptin and hot water extract of A. squamosa
were evaluated as shown in the Figure 3A,B. Sitagliptin an established inhibitor of DPP-IV enzyme,
reduced enzyme activity in a dose-dependent manner (1–10 µM) by 15–98% (p < 0.01–0.001, Figure 3A).
Hot water extract significantly inhibited DPP-IV activity by 8–22% at concentrations between 200 and
5000 µg/mL (p < 0.05–0.001; Figure 3B).
3.10. Effects of A. squamosa Leaves on Oral Glucose Tolerance and Insulin Responses
Oral administration of hot water extract of A. squamosa (250 mg/5 mL/kg) with glucose (18 mmol/kg
body weight) significantly (p < 0.05–0.01) improved glucose tolerance in high-fat fed rats compared to
glucose alone (Figure 3C). This was associated with a significantly increased plasma insulin response
at 30 min (p < 0.05, Figure 3D). It is notable that high-fat fed rats had a significantly higher level of
blood glucose (p < 0.01–0.001) and plasma insulin (p < 0.05–0.01) compared to the normal lean rats
(Figure 3C,D).
3.11. Effects of A. squamosa Leaves on DPP-IV Enzyme Activity In Vivo
High-fat fed rats receiving oral glucose (18 mmol/kg) plus extract (250 mg/5 mL/kg) showed a
reduction in DPP-IV enzyme activity (p < 0.05–0.01, Figure 3E) from 30 min onwards with 20–24%
decrease compared to the high-fat fed control rats (glucose alone). Sitagliptin and vidagliptin
(10 µmol/5 mL/kg), established inhibitors of DPP-IV used as positive controls, provoked reduced
enzyme activity by 69–71% from 30 min (p < 0.001, Figure 3E).
Plants 2020, 9, 1348 11 of 26Plants 2020, 9, x FOR PEER REVIEW 11 of 27 
Plants 2020, 9, x; doi: FOR PEER REVIEW www.mdpi.com/journal/plants 
 
Figure 3. Effects of hot water extract of A. squamosa on (A,B) DPP-IV enzyme activity in vitro, (C,D) glucose tolerance and (E) plasma DPP-IV in high-fat fed rats 
fasted for 6 h. Glucose tolerance, plasma insulin and DPP-IV enzyme activity were measured prior to and after oral administration of glucose alone (18 mmol/kg 
body weight, control) or with A. squamosa leaves (250 mg/5 mL/kg body weight). Values are Mean ± SEM for n = 3 for DPP-IV enzyme activity in vitro and n = 6 for 
glucose tolerance, plasma insulin and DPP-IV in vivo. * p < 0.05, ** p < 0.01 and *** p < 0.001, compared to normal control and Δ p < 0.05, ΔΔ p < 0.01 and ΔΔΔ p < 0.01 
compared to high-fat fed diet control.
Figure 3. Effects of hot water extract of A. squamosa on (A,B) DPP-IV enzyme activity in vitro, (C,D) glucose tolerance and (E) plasma DPP-IV in high-fat fed rats
fasted for 6 h. Glucose tolerance, plasma ins lin and DPP-IV enzyme activity were measured prior to and after oral administration of glucose alone (18 mmol/kg
body weight, contr l) or with A. squamosa leaves (250 mg/5 mL/kg body weight). Values are Mean ± SEM for n = 3 for DPP-IV enzyme activity in vitro and n = 6 for
glucose tolerance, plasma insulin and DPP-IV in vivo. * p < 0.05, ** p < 0.01 and *** p < 0.001, compared to n rmal control and ∆ p < 0.05, ∆∆ p < 0.01 and ∆∆∆ p < 0.01
compared to high-fat fed diet co trol.
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3.12. Effects of A. squamosa Leaves on Food Intake, Energy Intake, Fluid Intake, Body Weight, Non-Fasting
Blood Glucose, Plasma Insulin and DPP-IV Concentration in High-Fat Fed Rats
Administration of leaf extract (250 mg/5 mL/kg) to high-fat fed rats orally twice daily for 9 days
reduced food intake, energy intake, fluid intake and blood glucose by 16%, 17%, 10% and 7% respectively,
from day 6 onwards (p < 0.05–0.001, Figures 4A–C,E and 5D). This coincided with reduction in the body
weight with a 16% change from starting values (p < 0.05–0.01; Figure 4D). The extract also enhanced the
plasma insulin levels from 6-days onwards compared to high-fat fed diet controls (p < 0.05; Figures 4F
and 5E). This was accompanied by 16% decrease of DPP-IV enzyme activity compared to high-fat fed
diet control alone (p < 0.05, Figures 4G and 5F).
3.13. Effects of A. squamosa Leaves on Glucose Tolerance and, Associated Plasma Insulin and DPP-IV Levels in
High-Fat Fed Rats
After 6 days oral administration of A. squamosa (250 mg/5 mL/kg), oral glucose tolerance
(18 mmol/kg, body weight) was significantly improved (p < 0.001) from 30 min onwards compared to
high-fat fed controls (p < 0.05–0.01, Figure 5A). Similarly, A. squamosa treatment was associated with a
sharp increase in insulin secretion by 30 min after the oral glucose challenge (Figure 5B), with 1.4-fold
greater insulin responses (p < 0.05) than high-fat fed controls. A. squamosa (250 mg/5 mL/kg) also
reduced DPP-IV enzyme activity by 13–17% on 6-days treatment from 60 min onwards during oral
glucose tolerance test (Figure 5C; (p < 0.05–0.01)).
3.14. Effects of A. squamosa Leaves on Pancreatic Insulin and Islet Morphology in High-Fat Fed Rats
Pancreatic weights were similar in all groups of rats (Figure 5G) but pancreatic insulin content
was increased by 43% in high-fat fed treated rats compared to lean controls (p < 0.001, Figure 5H).
Treatment with A. squamosa significantly reduced the elevated insulin content by 21% (p < 0.001,
Figure 5H). Pancreatic islet morphology was evaluated in (A) lean-control, (B) high-fat fed diet control
and (C) high-fat fed diet rats treated for 9 days with hot water extract of A. squamosa (Figure 6A–J)).
In the high-fat fed group, the number of islets per mm2 was greater than in the lean control group
(p < 0.05, Figure 6J). Beta and alpha cell areas were also increased significantly as compared to lean
controls (p < 0.01–0.001, Figure 6E,F). A. squamosa produced a significant 15% reduction of the islet
area (p < 0.05, Figure 6D). The number of large and medium size islets was reduced significantly
(p < 0.05) and the number of small size islets increased (p < 0.01) after A. squamosa treatment (Figure 6G).
The beta and alpha cell areas were also decreased markedly (p < 0.05) in the treated group (Figure 6E,F).
Notably, the proportion of beta cells was higher in high-fat fed groups compared to the normal rats and
the % of alpha cells was decreased (p < 0.01–0.001, Figure 6H,I). Furthermore, the proportion of beta
cells were decreased in the treated group compared to high-fat fed control rats (p < 0.05, Figure 6I).
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intake, (D) body weight, (E) blood glucose, (F) plasma insulin (G) and DPP-IV enzyme activity in high-fat fed rats. A. squamosa leaves extract was administered 
orally (250 mg/5 mL/kg body weight) twice daily. Values are Mean ± SEM for n = 8 rats. * p < 0.05, ** p < 0.01 and *** p < 0.001 compared to lean control. Δ p < 0.05, ΔΔ 
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Figure 5. Chronic effects of twice daily oral administration of hot water extract of A. squamosa leaves on (A) glucose tolerance (B) plasma insulin and (C) plasma 
DPP-IV on day 6 and (D) blood glucose, (E) plasma insulin, (F) plasma DPP-IV, (G) pancreas weight and (H) pancreatic insulin content on day 9 in high-fat fed rats. 
A. squamosa leaves extract was administered orally (250 mg/5 mL/kg body weight) twice daily. Glucose tolerance was assessed by oral administration of glucose (18 
mmol/kg). Values are Mean ± SEM with n = 8. * p < 0.05, ** p < 0.01 and *** p < 0.001 compared to lean control. Δ p < 0.05, ΔΔ p < 0.01 ΔΔΔ p < 0.001 compared to high-fat 
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Figure 6. Effects of 9 days treatment of hot water extract of A. squamosa leaves on islet morphology in high-fat fed rats. Representative images of (A) lean control, 
(B) high-fat fed control and (C) high-fat fed rats treated with hot water extract of A. squamosa (250 mg/5 mL/kg), showing insulin in red, glucagon in green and DAPI 
in blue, (D) islet area, (E) alpha cell area, (F) beta cell area, (G) islet size distribution, (H) alpha cell percentage, (I) beta cell percentage and (J) number of islets (per 
mm2) respectively. Values are mean ± SEM for n = 8 (~100 islets per group). * p < 0.05, ** p < 0.01 and *** p < 0.001 compared to lean control. Δ p < 0.05 and ΔΔ p < 0.01 
compared to high-fat fed diet alone (control). 
 
Figure 6. Effects of 9 days treatment of hot water extract of A. squamosa leaves on islet morphology in high-fat fed rats. Representative images of (A) lean control, (B)
high-fat fed control and (C) high-fat fed rats treated with hot water extract of A. squamosa (250 mg/5 mL/kg), showing insulin in red, glucagon in green and DAPI in
blue, (D) islet area, (E) alpha cell area, (F) beta cell area, (G) islet size distribution, (H) alpha cell percentage, (I) beta cell percentage and (J) number of islets (per mm2)
respectively. Values are mean ± SEM for n = 8 (~100 islets per group). * p < 0.05, ** p < 0.01 and *** p < 0.001 compared to lean control. ∆ p < 0.05 and ∆∆ p < 0.01
co pared to high-fat fed diet alone (control).
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3.15. Purification and Structural Characterization of Purified Extract
Extract was purified using RP-HPLC and peak fractions were detected using UV detector of 254
and 360 nm and mass to charge ratio of peak samples were determined using LCMS (Figure 7A–E).
Molecular weights of peaks 1, 3 and 4 were 742.3, 594.3 and 590.3 Da (data not shown) whereas the
molecular weight of peak 2 was 610.3 Da (Figure 7B). Figure 7C–E shows an identical retention time
for (C) peak-2, (D) rutin and (E) peak-2 + rutin. Further structural characterization of the compounds
was obtained by NMR and the characteristics of the isolated compounds depicted in Figure 8A for 1H
and Figure 8B for 13C NMR are as presented below.
Rutin (C27 H30 O16): EI-MS m/z 610.3 Da [M]; (600 MHz, CD3OD, 1H-NMR (δ in ppm): 7.57
(dd, 1H, J = 2.4 Hz, J = 8.4 Hz), 6.78 (d, 1H, J = 8.4 Hz), 6.30 (s, 1H), 6.11 (s, 1H), 5.01 (s, 1H), 4.74
(d, 1H, J = 7.8 Hz), 4.2 (d, 1H, J = 1.8 Hz), 3.37–3.21 (m, 7H), 3.20 (d, 2H, J = 17.4 Hz), 1.18 (d,
3H, J = 6.6 Hz). 13C NMR (150 MHz, CD3OD, δ in ppm); 178.2 (CO-9), 164.6 (C-13), 161.8 (C-11),
157.9 (C-15), 157.0 (C-7), 148.8 (C-3), 144.4 (C-4), 134.4 (C-8), 122.1 (C-6), 121.7 (CH-1), 116.5 (CH-2),
114.7 (CH-5), 104.5 (C-10), 98.5 (CH-12), 93.4 (CH-14), 101.0 (C1-G), 74.3 (C2-G), 75.8 (C3-G), 72.5 (C4-G),
76.8 (C5-G), 68.3 (C6-G), 103.3 (C1-R), 73.7 (C2-R), 72.4 (C3-R), 72.5 (C4-R), 73.9 (C5-R), 16.5 (C6-R) (the
letters R and G respectively, symbolise the signals of glucose and rhamnose molecules).
For the primary flavonoid, rutin, the HPLC conditions outlined in the experimental section were
used to separate and quantify rutin within the samples. This revealed that amount of rutin in 1 mg/mL
of A. squamosa leaves extract after purification was 15–20%. This is in strong agreement with previous
studies the identification of the compound confirmed by HPLC, LCMS and NMR and their derivatives:
isoquercitrin and quercetin are presented in Figure 8.
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using linear gradients from 0% to 20% acetonitrile over 10 min, to 70% over 40 min. Details of peaks corresponding to A. squamosa leaves and rutin are presented in 
the chromatogram. UV detection was set at 220 and 360 nm and 1 mg/mL sample was injected for each run. In the chromatogram, P represents the peak in different 
retention time (RT). The mass-to-charge ratio (m/z) versus peak intensity was determined. Fragments of “peak-1 to 4” represents the molecular weight of unknown 
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Figure 7. Representative HPLC profile of (A) hot water extract of A. squamosa leaves, (B) LC-MS analysis of peak samples were separated on a Spectra System LC
using a Kinetex 5 µm F5 LC column ((150 × 4.6 mm) (Phenomenex), (C) Peak 2, (D) Rutin and (E) peak 2 + Rutin eluting from analytical C-18 column for over 40 min.
The column was equilibrated with 0.12% (v/v) TFA/water at flow rate of 5.0 and 1.0 mL/min respectively. The concentration of the eluting solution was raised using
linear gradients from 0% to 20% acetonitrile over 10 min, to 70% over 40 min. Details of peaks corresponding to A. squamosa leaves and rutin are presented in the
chromatogram. UV detection was set at 220 and 360 nm and 1 mg/mL sample was injected for each run. In the chromatogram, P represents the peak in different
retention time (RT). The mass-to-charge ratio (m/z) versus peak intensity was determined. Fragments of “peak-1 to 4” represents the molecular weight of unknown
compounds with m/z 742.3 to 590.3 Da (data not shown) respectively.
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Figure 8. (A) 1H-NMR, (B) C13-NMR spectrum and isolated compound (rutin) from peak-2 sample obtained following RP-HPLC of hot water extract of A. squamosa 
leaves and its metabolites, isoquercitrin and quercetin. Proton-decoupled natural abundance C13-NMR and 1H-NMR spectrum of peak-2 sample of hot water extract 
of A. squamosa leaves (obtained from chromatograph over the period of 0 to 70% acetonitrile from 0 to 40 min with retention time of 25 min) at 40 °C. The spectrum 
was obtained at 600 and 150 MHz after 119,044 transients (14 h) by the pulsed Fourier transform method on a Varian XL-100 A spectrometer. Representative structure 
of flavonoids, corresponding to the structure of rutin (Quercetin 3-rutinoside), isoquercitrin and quercetin are C27H30O16), C21H20O12 and C15H10O7. 
Figure 8. (A) 1H-NMR, (B) C13-NMR spectrum and isolated compound (rutin) from peak-2 sample obtained following RP-HPLC of hot water extract of A. squamosa
leaves and its metabolites, isoquercitrin and quercetin. Proton-decoupled natural abundance C13-NMR and 1H-NMR spectrum of peak-2 sample of hot water extract
of A. squamosa leaves (obtained from chromatograph over the period of 0 to 70% acetonitrile from 0 to 40 min with retention time of 25 min) at 40 ◦C. The spectrum was
obtained at 600 and 150 MHz after 119,044 transients (14 h) by the pulsed Fourier transform method on a Varian XL-100 A spectrometer. Representative structure of
flavonoids, corresponding to the structure of rutin (Quercetin 3-rutinoside), isoquercitrin and quercetin are C27H30O16), C21H20O12 and C15H10O7.
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3.16. Effects of Peak Samples of A. squamosa Leaves on Insulin Release In Vitro
The effects of a range of concentrations of peak sample of A. squamosa leaf on insulin secretion
from BRIN-BD11 cells are illustrated in Figure 9A. In these studies, alanine (10 mM) was used as
a positive control. There was a concentration-dependent release of insulin observed by the peak-2
fraction (610.3 Da, 8 to 1000 µg/mL)) compared to control (5.6 mM glucose) (p < 0.05–0.001, Figure 9A).
Peak-3 and peak-4 stimulated insulin release only at higher concentrations (1000 µg/mL) compared to
control (5.6 mM glucose) (data not shown). The cell viability was not affected by various concentrations
of the peaks between 8 to 1000 µg/mL (data not shown).
3.17. Effects of Isolated Compound Rutin on Insulin Release In Vitro
The effects of a range of concentrations of rutin, isolated from A. squamosa leaves, on insulin
secretion from BRIN-BD11 cells are illustrated in Figure 9B. In these studies, alanine (10 mM) was
used as a positive control. Rutin, stimulated insulin secretion at concentration range 8–1000 µg/mL
(p < 0.05–0.001, Figure 9B). LDH release was increased at a higher concentration of 1000 µg/mL (data
not shown).
3.18. Effects of Isolated Compound Rutin on Beta Cell Membrane Depolarization and Intracellular Calcium
Ion Concentration
Rutin (50 µg/mL) induced membrane depolarization in the BRIN-BD11 cells at 5.6 mM glucose
(Figure 9C). The magnitude of the effect was lower than that generated by a high depolarizing 30 mM
concentration of KCl but was considerably greater (p < 0.05) than that produced by glucose alone.
Similarly, rutin (50 µg/mL) and alanine (10 mM) produced a significant increase in intracellular Ca2+
(p < 0.05; Figure 9D).
3.19. Effects of Isolated Compound Rutin on Oral Glucose Tolerance and Insulin Responses
Oral administration of rutin (100 mg/kg body weight) with glucose (18 mmol/kg) to mice
significantly (p < 0.01–0.001) lowered blood glucose during oral glucose tolerance test at 30 and 60 min
by 18–20% compared to the control (glucose alone) (Figure 9E). Rutin also increased plasma insulin at
30 and 60 min by 30–33% following administration with glucose (p < 0.05–0.01, Figure 9F).
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rutin on insulin r lease from BRIN-BD11 cells, (C) membrane po ntial nd (D) intr cellular calcium
expressed as RFU and r sp ctive area under the curve, (E) glucose tolera ce and (F) plasma ins in.
Mi e were fasted for 12 h and adminis er d glucose (18 mmol/kg body weight) by oral gavage with or
without rutin (100 mg/kg body weight). Valu s are Mean ± SEM for n = 8 for insulin rele se, n = 6
for membrane potential and intracellular calcium and n = 7 for glucose tolerance and plasma insulin.
* p < 0.05, ** p < 0.01 and *** p < 0.001 compared to control.
4. Discussion
The A. squamosa, also known as “ata” in Bengali, has been claimed as a potential anti-diabetic
plant [19,20]. However, its mechanism of action(s) is still poorly understood. In this study,
we investigated a wide range of potential antidiabetic effects of A. squamosa hot water extract including
in vitro studies on insulin secretion, cellular glucose uptake, DPP-IV activity, starch digestion, glucose
diffusion and glycation. Moreover, we conducted in vivo studies in high-fat fed rats to evaluate acute
and longer-term actions on glucose homeostasis, islet morphology and pancreatic insulin content.
Plants 2020, 9, 1348 21 of 26
Extract of A. squamosa leaves stimulated concentration-dependent insulin secretion from clonal
BRIN BD11 cells as well as potentiating glucose-induced insulin release from isolated mouse islets.
Mechanistic studies performed with fluorescent indicator dyes and modulators of insulin release,
such as diazoxide (KATP-channel opener) and verapamil (voltage-dependent Ca2+ channel blocker),
to interrogate specific signal transduction pathways revealed an insulinotropic action dependent
on membrane depolarization and influx of intracellular Ca2+. However, effects persisted Ca2+ free
buffer and in the presence of the sulphonylurea, tolbutamide, or 30 mM KCl which both strongly
depolarize beta cells. This suggests additional complementary actions of A. squamosa via KATP
and Ca2+-independent pathways involving adenylate cyclase/cAMP, phosphatidylinositol kinases or
direct impacts on exocytotic machinery [11]. Consistent with the former, effects of A. squamosa were
significantly enhanced by cAMP phosphodiesterase inhibition using IBMX. Interestingly, traditional use
of A. squamosa in asthma treatment [37] involves elevation of cAMP in bronchial smooth muscles,
relaxing the airway passage and downregulating cellular replication in smooth muscles [38].
Using differentiated 3T3L1 adipocytes, A. squamosa was shown to enhance cellular glucose uptake
in the absence but particularly in presence of sub-maximal stimulatory concentration of insulin.
This strongly suggests that a component of the antidiabetic action of A. squamosa involves promotion
of insulin action as well as insulin secretion. In target cells, insulin initiates a signal transduction
via binding to insulin receptors which increases glucose uptake via recruitment of GLUT4 to plasma
membrane with subsequent metabolism and storage [39]. Previous studies have shown that activation
of Akt and p70 S6 kinase can increase glycogen, lipid, and protein synthesis and in turn promote
glucose uptake [40]. However further studies are required to elucidate the possible involvement of
this and other mechanisms of action of A. squamosa extract.
Additional antidiabetic actions of A. squamosa possibly involve effects in the GI-tract, so effects on
carbohydrate digestion were explored in vitro. Acarbose, an α-glucosidase inhibitor, was used as a
reference standard which almost abolished glucose liberation from starch. A. squamosa extract was also
effective in inhibiting starch digestion which can be envisaged to greatly retard glucose absorption
in vivo. Interestingly, previous studies on plant alkaloids and flavonoids revealed their ability to exert
α-glucosidase inhibitory action [29,41] which are consistent with our present observations. We also
used a simple in vitro system to study effects of A. squamosa extract on glucose diffusion [33]. Like our
positive control, guar gum, A. squamosa substantially reduced glucose diffusion in this in vitro model,
mediated primarily by viscosity changes.
Glycation is a common post translational modification of proteins in diabetes and is strongly
implicated in the genesis of long-term complications [42]. Insulin glycation is an example of glycation
of short-lived protein that can lead to insulin resistance because of its reduced biological activity [43].
In our study, A. squamosa inhibited the insulin glycation in vitro, suggesting its utility in helping to
prevent glycation of functional and structural proteins in the progression of insulin resistance and
diabetic complications. Recent studies of A. squamosa have also reported significant anti-oxidant
properties [44] that might also protect against beta cell damage and apoptosis.
These in vitro observations are consistent with potential strong antidiabetic efficacy of A. squamosa
and our studies were therefore extended to examine rats fed high-fat diet with obesity and metabolic
abnormalities, such as insulin resistance and T2DM [45]. In acute studies, oral administration of
high-fat fed rats with A. squamosa together with a glucose load improved glucose tolerance with
enhanced plasma insulin responses. These results were consistent with the in vitro observations and
encouraged the longer- term studies looking at effects of twice daily dosing with A. squamosa extract
in high-fat fed rats. This revealed significant improvements in non-fasting blood glucose, glucose
tolerance, plasma insulin, food, fluid and energy intake.
Several pharmacological approaches have been made to treat T2DM by targeting the incretin
system, including development of oral DPPIV inhibitors to prevent GLP-1 degradation [46]. In our
studies, incubation with A. squamosa extract resulted in significant concentration-dependent inhibition of
DPP-IV enzyme activity which, although less potent than sitagliptin, translated to readily demonstrable
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acute enzyme inhibitory effects in high-fat fed rats. In our longer-term studies, administration of
plant extract similarly suppressed plasma DPP-IV enzyme activity suggesting that part of metabolic
improvement might involve potentiation of GLP-1 and GIP actions.
More detailed evaluation of these longer-term pancreatic actions of A. squamosa revealed reversal
of the high-fat fed induced increases in pancreatic insulin content, islet size, beta cell area and alpha cell
area in high-fat fed rats. The number of small size islets increased significantly. However, the number
of large and medium size islets decreased. There was also a significant reduction in the number of
islets per mm2. Pancreatic insulin content decreased and so did the area of the islet and beta cells
together with a tendency towards decreased numbers of beta cells. The most plausible explanation for
these effects of A. squamosa is the alleviation of insulin resistance caused by high-fat feeding which
increases pancreatic insulin demand. Additionally, the restoration of normal blood glucose control can
be envisaged to diminish the direct beta cell effects of A. squamosa due to their glucose dependency.
Phytochemical isolation of insulinotropic constituents of A. squamosa was performed to structurally
identify some of the main compounds responsible for the antidiabetic properties. RP-HPLC fraction
isolated as peak-2 revealed a molecular mass of 610 Da which had the same molecular mass and retention
time as commercially available rutin. The spectrum obtained of 1H NMR displayed characteristic
proton signals at 7.57, 6.78, 6.30, 5.11 and 5.01 PPM. In contrast, five aromatic protons were observed in
the spectrum of 1H NMR; ortho-coupling protons were detected at 7.57 (dd, 1H, J = 2.4 Hz, J = 8.4 Hz)
and 6.78 (d, 1H, J = 8.4 Hz) and meta-coupling protons at 6.11 (s, 1H) and 5.01 (s, 1H). The 1H NMR
spectrum also endorsed glucose and rhamnose moieties at 4.74 ppm with the glucose anomeri proton
signal and 4.42 ppm with the rhamnose signal. At 1.18 ppm (d, 3H, J = 6.6 Hz), a doublet of rhamnose
methyl group was observed at a high field. The remaining protons resonated between 3.37 and
3.21 ppm in the sugar moiety. A doublet of methyl group of rhamnose was also observed at high field at
1.18 (d, 3H, J = 6.6 Hz). These features identify the peak as rutin with a chemical structure of C27H30O16.
Rutin metabolites, isoquercitrin and quercetin, were also detected in the insulin-releasing peaks
confirming earlier studies of flavonoids present in A. squamosa [47]. Further studies using rutin isolated
from the A. squamosa extract, revealed that the compound dose-dependently stimulated insulin release
from BRIN-BD11 cells and improved both in vivo glucose tolerance and plasma insulin responses.
Other studies have also suggested that both rutin and isoquercitrin, inhibit DPP-IV enzyme activity by
directly blocking the DPP-IV active binding site [48,49].
Interestingly, flavonoids such as rutin have been shown previously to exert antihyperglycaemic
effects in STZ-induced diabetic rats [50]. This was associated with inhibition of α-glucosidase
activity [51] and increased insulin secretion from rat pancreatic islets [52]. Rutin is widely distributed in
edible plants [53] can be biotransformed into quercetin and isoquercitrin [54,55] which may have better
antidiabetic properties. Thus, quercetin is absorbed in small intestine at a faster rate than rutin [53],
yielding higher plasma concentrations and greater bioavailability in man [53]. These observations
focus attention on further studies evaluating the therapeutic actions of flavonoids in diabetes.
5. Conclusions
In summary, this research has demonstrated that A. squamosa plant extract exhibits clear antidiabetic
properties mediated by broad spectrum of actions, including enhancing insulin secretion/action,
inhibiting starch digestion and protein glycation, delaying glucose absorption and suppressing DPP-IV
enzyme activity. Several phytochemicals are likely to contribute to such effects but rutin isolated by
bioassay led purification appears to be the major insulinotropic agent. These studies indicate the
suitability of A. squamosa as a simple multi-purpose dietary adjunct for treatment of T2DM and as a
source of antidiabetic agents.
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